Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

European study establishes a global prevalence of young-onset dementia

Staff Writer
Staff Writer 10 months ago
Updated 2021/07/19 at 11:41 PM
Share
SHARE

In JAMA Neurology, a team of European researchers established the global prevalence of young-onset dementia, as part of a systematic review.

Researchers probed 74 studies, with a total of nearly 2.8 million patients included, using databases such as PubMed, Embase, CINAHL, and PsycInfo.

Young-onset dementia is characterized as symptoms of dementia occurring before the age of 65, the baseline age range for late adulthood.

“Studies containing data on the prevalence of dementia in individuals younger than 65 years were screened by 2 researchers for inclusion in a systematic review and meta-analysis,” the JAMA report reads.

“In this systematic review, a total of 95 studies were included, of which 74 studies were included in the meta-analysis; the global age-standardized prevalence of young-onset dementia was 119.0 per 100,000 population aged 30 to 64 years. Estimates increased from 1.1 per 100,000 population aged 30 to 34 years to 77.4 per 100 000 population aged 60 to 64 years.”

The study found that the young-onset dementia prevalence was 119.0 per 100,000 population.

“These results should help policy makers organize sufficient health care for this subgroup of individuals with dementia,” the study concluded.

You Might Also Like

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

Study finds no structural brain change during mindfulness-based stress training

Study finds diet may be a contributing factor in ADHD symptoms associated in children

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

ALS experimental drug NU-9 more efficacious than existing FDA-approved drugs

TAGGED: epidemiology, cognition, dementia
Staff Writer July 19, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Study finds excessive caffeine intake might be associated with a higher risk of osteoporosis
Next Article Coffee consumption may not increase the risk of arrhythmias in most people

Recommended

Clinical

Type 2 diabetes may lead to a significant increase in brain aging and cognitive decline

1 Min Read
Clinical

Study finds no structural brain change during mindfulness-based stress training

1 Min Read
Clinical

Study finds diet may be a contributing factor in ADHD symptoms associated in children

1 Min Read
Clinical

New research claims COVID-19 contagion may raise the risk of neurodegenerative disorder

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?